Ocular Therapeutix (NASDAQ:OCUL) is up 8.6% after hours, adding on to a 32.4% gain today, after a healthy price target bump from Piper Sandler.
Shares jumped on high volume today after its quarterly results and encouraging data on an eye implant.
Piper raised its target to $11 from a previous $7; that now implies 52% upside from the closing price of $7.23.
https://seekingalpha.com/news/3548837-ocular-therapeutixplus-9-piper-hikes-target
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.